Effect of Different Polymer Modifiers on the Long-Term Rutting and Cracking Resistance of Asphalt Mixtures

To evaluate the long-term performances of different polymer-modified asphalt mixtures, three modifiers were chosen to modify AC-13 (defined as the asphalt concrete with the aggregate nominal maximum particle size of 13.2 mm); namely, high viscosity modifier (HVM), high modulus modifier (HMM), and anti-rutting agent (ARA). The deformation and cracking resistance of different polymer-modified mixtures were checked at different aging conditions (unaged, short-term aged, and long-term aged for 5, 10, and 15 days respectively). The results of the Hamburg wheel-track test and uniaxial penetration test (UPT) showed that the rutting resistance of all asphalt mixtures changed in a V-shape as the aging progressed. From the unaged stage to the long-term aging stage (5 days), the rutting resistance decreases gradually. While after the long-term aging stage (5 days), the rutting resistance increases gradually. Results from the semicircular bending test (SCB) and the indirect tensile asphalt cracking test (IDEAL-CT) indicated that the cracking resistance of all the mixtures gradually decline with the deepening of the aging degree, indicating that aging weakens the crack resistance of asphalt mixtures. Additionally, test results showed that the rutting resistance of ARA AC-13 (defined as AC-13 containing ARA) is the best, the cracking resistances of ARA AC-13, HMM AC-13 (defined as AC-13 containing HMM) and HVM AC-13 (defined as AC-13 containing HVM) have no significant difference, and different polymer modifiers had different sensitivities to aging due to the polymer content and the type of modifier. The conclusions of this study help to further understand the long-term performance of polymer-modified asphalt mixtures during service life and to help guide the selection of modifiers for mixtures

Hybrid membrane camouflaged Prussian blue nanoparticles with cinobufagin loading for chemo/photothermal therapy of colorectal cancer

The natural compound of cinobufagin (CS-1) has showed potential application for colorectal cancer therapy. However, the limitation of hydrophobicity and cardiotoxicity appealed for the improvement of compound formulation. Meanwhile, sole chemotherapy for colorectal cancer (CRC) is facing the challenges of finite accumulation of drugs in tumor sites and nonspecific toxicity. In order to overcome these limitations, cinobufagin loaded in Prussian Blue nanoparticles (PC NPs) were prepared for CRC therapy by combining with photothermal therapy (PTT). The hybrid cell membranes coating was adopted to endow immune escape and tumor homing capacity of PC@M NPs. Both in vitro and in vivo assay demonstrated that the chemo/photothermal therapy not only suppressed CRC growth, but also inhibited the metastasis of primary by downregulating the expression of Vimentin, matrix metalloproteinase-9 (MMP-9) and hypoxia-inducible factor1-alpha (HIF-1α). Moreover, this strategy modulated the intestinal microbiota of CRC-bearing mice to a normal level in some extent. Taken together, this proposed nanoplatform presents a potential strategy for CRC therapy

Strain-sensitive superconductivity in kagome metals KV3_3Sb5_5 and CsV3_3Sb5_5 probed by point-contact spectroscopy

The kagome lattice is host to flat bands, topological electronic structures, Van Hove singularities and diverse electronic instabilities, providing an ideal platform for realizing highly tunable electronic states. Here, we report soft- and mechanical- point-contact spectroscopy (SPCS and MPCS) studies of the kagome superconductors KV$_3$Sb$_5$ and CsV$_3$Sb$_5$. Compared to the superconducting transition temperature $T_{\rm c}$ from specific heat measurements (2.8~K for CsV$_3$Sb$_5$ and 1.0~K for KV$_3$Sb$_5$), significantly enhanced values of $T_{\rm c}$ are observed via the zero-bias conductance of SPCS ($\sim$4.2~K for CsV$_3$Sb$_5$ and $\sim$1.8~K for KV$_3$Sb$_5$), which become further enhanced in MPCS measurements ($\sim$5.0~K for CsV$_3$Sb$_5$ and $\sim$3.1~K for KV$_3$Sb$_5$). While the differential conductance curves from SPCS are described by a two-gap $s$-wave model, a single $s$-wave gap reasonably captures the MPCS data, likely due to a diminishing spectral weight of the other gap. The enhanced superconductivity probably arises from local strain caused by the point-contact, which also leads to the evolution from two-gap to single-gap behaviors in different point-contacts. Our results demonstrate highly strain-sensitive superconductivity in kagome metals CsV$_3$Sb$_5$ and KV$_3$Sb$_5$, which may be harnessed in the manipulation of possible Majorana zero modes

Polymeric nanoparticles developed by vitamin E-modified aliphatic polycarbonate polymer to promote oral absorption of oleanolic acid

Oleanolic acid (OA) exhibited good pharmacological activities in the clinical treatment of hypoglycemia, immune regulation, acute jaundice and chronic toxic hepatitis. However, the oral delivery of OA is greatly limited by its inferior water solubility and poor intestinal mucosa permeability. Herein, we developed a novel polymeric nanoparticle (NP) delivery system based on vitamin E modified aliphatic polycarbonate (mPEG-PCC-VE) to facilitate oral absorption of OA. OA encapsulated mPEG-PCC-VE NPs (OA/mPEG-PCC-VE NPs) showed uniform particle size of about 170 nm with high drug loading capability (8.9%). Furthermore, the polymeric mPEG-PCC-VE NPs, with good colloidal stability and pH-sensitive drug release characteristics, significantly enhanced the in vitro dissolution of OA in the alkaline medium. The in situ single pass intestinal perfusion (SPIP) studies performed on rats demonstrated that the OA/mPEG-PCC-VE NPs showed significantly improved permeability in the whole intestinal tract when compared to OA solution, especially for duodenum and colon. As a result, the in vivo pharmacokinetics study indicated that the bioavailability of OA/mPEG-PCC-VE NPs showed 1.5-fold higher than commercially available OA tablets. These results suggest that mPEG-PCC-VE NPs are a promising platform to facilitate the oral delivery of OA

Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X

<div><p>Abstract Background: Although a proportion of CSX patients have impaired brachial artery flow-mediated dilatation (FMD) in response to hyperemia, suggesting that endothelial dysfunction in these patients may be systemic and not just confined to the coronary circulation; the underlying mechanisms triggering endothelial dysfunction in these patients are still incompletely understood. Objectives: To assess the association of the index of Microcirculatory Resistance (IMR) with endothelial dysfunction and inflammation in patients with CSX. Methods: We studied 20 CSX patients and 20 age and gender-matched control subjects. Thermodilution-derived coronary flow reserve (CFR) and IMR were measured using a pressure-temperature sensor-tipped guidewire. Brachial artery FMD was measured using high-resolution, two-dimensional ultrasound images obtained with a Doppler ultrasound device (HDI-ATL 5000, USA) with a 5 MHz to 12 MHz linear-array transducer. Results: Compared with in control subjects, CFR was significantly lower (2.42 ± 0.78 vs. 3.59 ± 0.79, p < 0.001); IMR was higher (32.2 ± 8.0 vs. 19.5 ± 5.5, p < 0.001); the concentration of hs-CRP and FMD was higher (4.75 ± 1.62 vs. 2.75 ± 1.50; 5.24 ± 2.41 vs. 8.57 ± 2.46, p < 0.001) in CSX patients. The Duke treadmill score (DTS) was correlated positively to CFR and FMD (0.489 and 0.661, p < 0.001), it was negative to IMR and hsCRP (-0.761 and -0.087, p < 0.001) in CSX patients. Conclusions: The main finding in this study is that the DTS measured in patients with CSX was associated to hsCRP and FMD. Moreover, the independent effects of exercise tolerance can significantly impair FMD and hsCRP in CSX patients; especially it is particularly important to whom where FMD was associated negatively with IMR.</p></div